These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 26625717)
41. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells. Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532 [TBL] [Abstract][Full Text] [Related]
42. Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery. Tagami T; Suzuki T; Matsunaga M; Nakamura K; Moriyoshi N; Ishida T; Kiwada H Int J Pharm; 2012 Jan; 422(1-2):280-9. PubMed ID: 22101286 [TBL] [Abstract][Full Text] [Related]
43. Comparison of anti-EGFR-Fab' conjugated immunoliposomes modified with two different conjugation linkers for siRNa delivery in SMMC-7721 cells. Deng L; Zhang Y; Ma L; Jing X; Ke X; Lian J; Zhao Q; Yan B; Zhang J; Yao J; Chen J Int J Nanomedicine; 2013; 8():3271-83. PubMed ID: 24023515 [TBL] [Abstract][Full Text] [Related]
44. B cell-intrinsic toll-like receptor 7 is responsible for the enhanced anti-PEG IgM production following injection of siRNA-containing PEGylated lipoplex in mice. Hashimoto Y; Abu Lila AS; Shimizu T; Ishida T; Kiwada H J Control Release; 2014 Jun; 184():1-8. PubMed ID: 24727075 [TBL] [Abstract][Full Text] [Related]
45. Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNA. Furst T; Dakwar GR; Zagato E; Lechanteur A; Remaut K; Evrard B; Braeckmans K; Piel G J Control Release; 2016 Aug; 236():68-78. PubMed ID: 27329774 [TBL] [Abstract][Full Text] [Related]
46. Reduced in vitro and in vivo toxicity of siRNA-lipoplexes with addition of polyglutamate. Schlegel A; Bigey P; Dhotel H; Scherman D; Escriou V J Control Release; 2013 Jan; 165(1):1-8. PubMed ID: 23123257 [TBL] [Abstract][Full Text] [Related]
48. Physicochemical characterization of anionic lipid-based ternary siRNA complexes. Kapoor M; Burgess DJ Biochim Biophys Acta; 2012 Jul; 1818(7):1603-12. PubMed ID: 22465067 [TBL] [Abstract][Full Text] [Related]
49. Gene delivery with active targeting to ovarian cancer cells mediated by folate receptor alpha. He Z; Yu Y; Zhang Y; Yan Y; Zheng Y; He J; Xie Y; He G; Wei Y; Song X J Biomed Nanotechnol; 2013 May; 9(5):833-44. PubMed ID: 23802413 [TBL] [Abstract][Full Text] [Related]
50. PEGylated and non-PEGylated siRNA lipoplexes formulated with cholesteryl cytofectins promote efficient luciferase knockdown in HeLa tat luc cells. Daniels A; Singh M; Ariatti M Nucleosides Nucleotides Nucleic Acids; 2013; 32(4):206-20. PubMed ID: 24001194 [TBL] [Abstract][Full Text] [Related]
51. Efficient intracellular siRNA delivery strategy through rapid and simple two steps mixing involving noncovalent post-PEGylation. Kong WH; Sung DK; Shim YH; Bae KH; Dubois P; Park TG; Kim JH; Seo SW J Control Release; 2009 Sep; 138(2):141-7. PubMed ID: 19426771 [TBL] [Abstract][Full Text] [Related]
52. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA. Bouxsein NF; McAllister CS; Ewert KK; Samuel CE; Safinya CR Biochemistry; 2007 Apr; 46(16):4785-92. PubMed ID: 17391006 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of pulmonary cancer progression by epidermal growth factor receptor-targeted transfection with Bcl-2 and survivin siRNAs. Lee YK; Lee TS; Song IH; Jeong HY; Kang SJ; Kim MW; Ryu SH; Jung IH; Kim JS; Park YS Cancer Gene Ther; 2015 Jul; 22(7):335-43. PubMed ID: 25857361 [TBL] [Abstract][Full Text] [Related]
54. Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes. Schlegel A; Largeau C; Bigey P; Bessodes M; Lebozec K; Scherman D; Escriou V J Control Release; 2011 Jun; 152(3):393-401. PubMed ID: 21497175 [TBL] [Abstract][Full Text] [Related]
55. Hydration of surfactant-modified and PEGylated cationic cholesterol-based liposomes and corresponding lipoplexes by monitoring a fluorescent probe and the dielectric relaxation time. Maitani Y; Nakamura A; Tanaka T; Aso Y Int J Pharm; 2012 May; 427(2):372-8. PubMed ID: 22348874 [TBL] [Abstract][Full Text] [Related]
56. Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome. Wang J; Ayano E; Maitani Y; Kanazawa H Int J Pharm; 2017 May; 523(1):217-228. PubMed ID: 28330734 [TBL] [Abstract][Full Text] [Related]
57. Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules. Herringson TP; Altin JG J Control Release; 2009 Nov; 139(3):229-38. PubMed ID: 19595724 [TBL] [Abstract][Full Text] [Related]
58. [Cell penetrating peptides enhance intracellular translocation and function of siRNA encapsulated in Pegylated liposomes]. Wang W; Tang N; Zhang CL; Liu XJ; Hu H; Zhang ZX; Liang W Yao Xue Xue Bao; 2006 Feb; 41(2):142-8. PubMed ID: 16671545 [TBL] [Abstract][Full Text] [Related]
59. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice. Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295 [TBL] [Abstract][Full Text] [Related]
60. PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stability. Godinho BM; Ogier JR; Quinlan A; Darcy R; Griffin BT; Cryan JF; O'Driscoll CM Int J Pharm; 2014 Oct; 473(1-2):105-12. PubMed ID: 24992319 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]